Literature DB >> 25349808

Microbiologic spectrum of acute and chronic dacryocystitis.

Bahram Eshraghi1, Parisa Abdi1, Mohammadreza Akbari1, Masoud Aghsaei Fard1.   

Abstract

AIM: To report the microbiological spectrum of acute and chronic dacrocystitis.
METHODS: Retrospective study on 100 patients who presented to the ophthalmic plastic clinic of a tertiary eye care center from May 2011 and April 2013 with acute and chronic dacryocystitis was reviewed for demographic and microbiological profile. The culture results and organisms isolated were recorded.
RESULTS: Sixty patients had acute onset and the remaining 40 patients had chronic onset dacryocystitis. The female to male ratio was 1.78. The mean age of patients was 44y. Gram-positive organisms were the most commonly isolated accounting for 54%, and the commonest species isolated was S. aureus in 26%. Percentage of gram positive cultures was higher in chronic dacryocystitis than acute ones (82% vs 48% of positive cultures; P=0.003). Also in culture positive acute dacryocystitis, gram negative species were found in 52% of eyes but only in 18% of chronic dacryocystitis.
CONCLUSION: Gram negative bacteria, culture negative samples, unusual and more virulent organisms are more common in acute dacryocystitis than chronic ones. The results of this study have significant bearing on the treatment of patients with dacrocystitis.

Entities:  

Keywords:  acute; bacteriology; chronic; dacrocystitis; epiphora

Year:  2014        PMID: 25349808      PMCID: PMC4206896          DOI: 10.3980/j.issn.2222-3959.2014.05.23

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  19 in total

1.  Clinical profile and management outcome of acute dacryocystitis: two decades of experience in a tertiary eye care center.

Authors:  Mohammad Javed Ali; Surbhi D Joshi; Milind N Naik; Santosh G Honavar
Journal:  Semin Ophthalmol       Date:  2013-10-30       Impact factor: 1.975

2.  Aerobic and anaerobic microbiology of dacryocystitis.

Authors:  I Brook; E H Frazier
Journal:  Am J Ophthalmol       Date:  1998-04       Impact factor: 5.258

3.  Orbital abscess secondary to acute dacryocystitis.

Authors:  E Warrak; P Khoury
Journal:  Can J Ophthalmol       Date:  1996-06       Impact factor: 1.882

4.  Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis.

Authors:  Daniel Briscoe; Alexander Rubowitz; Ehud Assia
Journal:  Orbit       Date:  2005-03

5.  Bacteriological study of dacryocystitis among patients attending in Menelik II Hospital, Addis Ababa, Ethiopia.

Authors:  Aster Kebede; Yilikal Adamu; Abebe Bejiga
Journal:  Ethiop Med J       Date:  2010-01

6.  Lacrimal sac empyema incision and drainage followed by early external dacryocystorhinostomy.

Authors:  Bahram Eshraghi; Hesam Hashemian; Masoud Aghsaei Fard; Mona Safizadeh
Journal:  Orbit       Date:  2013-07-22

7.  The microbiologic spectrum of dacryocystitis: a national study of acute versus chronic infection.

Authors:  David M Mills; Marc G Bodman; Dale R Meyer; Asa D Morton
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2007 Jul-Aug       Impact factor: 1.746

8.  Management of acute dacryocystitis in adults.

Authors:  K V Cahill; J A Burns
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1993       Impact factor: 1.746

9.  Acquired dacryocystitis: microbiology and conservative therapy.

Authors:  V Huber-Spitzy; F J Steinkogler; E Huber; E Arocker-Mettinger; M Schiffbänker
Journal:  Acta Ophthalmol (Copenh)       Date:  1992-12

10.  The microbiological profile of lacrimal abscess: two decades of experience from a tertiary eye care center.

Authors:  Mohammad Javed Ali; Swapna R Motukupally; Surbhi D Joshi; Milind N Naik
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-07-27
View more
  9 in total

1.  Role of Histomorphology and Chronic Inflammation Score in Chronic Dacryocystitis.

Authors:  Sudipta Chakrabarti; Senjuti Dasgupta; Manas Banerjee; Debashis Pal
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Bacterial agents and changes in drug susceptibilities in cases of chronic dacryocystitis, Southern China.

Authors:  Chengxiu Liu; Bowen Wang; Xinbo Gao; Xuanwei Liang; Pengxia Wan; Yingfeng Shao; Jiahui Liu; Liping Lin; Zhichong Wang
Journal:  Int Ophthalmol       Date:  2020-08-19       Impact factor: 2.031

3.  Modified External Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction.

Authors:  Hans Raj Sharma; Ashok K Sharma; Rajni Sharma
Journal:  J Clin Diagn Res       Date:  2015-10-01

4.  How Important Is the Etiology in the Treatment of Epiphora?

Authors:  Mahmut Oğuz Ulusoy; Sertaç Argun Kıvanç; Mehmet Atakan; Berna Akova-Budak
Journal:  J Ophthalmol       Date:  2016-08-10       Impact factor: 1.909

5.  Conjunctival bacterial flora in fellow eyes of patients with unilateral nasolacrimal duct obstruction and its changes after successful dacryocystorhinostomy surgery.

Authors:  Bahram Eshraghi; Sayyed Amirpooya Alemzadeh; Zohreh Abedinifar
Journal:  J Curr Ophthalmol       Date:  2016-12-03

6.  Microbiological study of dacryocystitis in northwest of Iran.

Authors:  Fatemeh Eslami; Hamid Reza Ghasemi Basir; Abbas Moradi; Shokoufe Heidari Farah
Journal:  Clin Ophthalmol       Date:  2018-09-25

7.  The microbiologic spectrum of dacryocystitis.

Authors:  Ban Luo; Mu Li; Nan Xiang; Weikun Hu; Rong Liu; Xiaoqin Yan
Journal:  BMC Ophthalmol       Date:  2021-01-11       Impact factor: 2.209

8.  Common bacterial causes of external ocular infections, associated risk factors and antibiotic resistance among patients at ophthalmology unit of Felege Hiwot Referral Hospital, Northwest Ethiopia: a cross-sectional study.

Authors:  Zimam Ayehubizu; Wondemagegn Mulu; Fantahun Biadglegne
Journal:  J Ophthalmic Inflamm Infect       Date:  2021-03-01

9.  Differently Expressed Circular RNAs in Lacrimal Sacs From Patients With Chronic Dacryocystitis.

Authors:  Yue Li; Xueru Liu; Wenyue Zhang; Xuefei Song; Leilei Zhang; Caiwen Xiao
Journal:  Front Genet       Date:  2022-02-28       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.